Enovix Co. (NASDAQ:ENVX - Get Free Report) rose 23.4% during trading on Wednesday . The stock traded as high as $6.65 and last traded at $6.74. Approximately 7,073,953 shares traded hands during trading, an increase of 10% from the average daily volume of 6,405,281 shares. The stock had previously closed at $5.46.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Craig Hallum dropped their price objective on shares of Enovix from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Cantor Fitzgerald restated an "overweight" rating and set a $30.00 price target on shares of Enovix in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $20.30.
Get Our Latest Research Report on Enovix
Enovix Trading Up 0.5 %
The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The firm has a market capitalization of $1.15 billion, a PE ratio of -4.14 and a beta of 1.98. The firm's fifty day moving average is $8.66 and its two-hundred day moving average is $9.83.
Enovix (NASDAQ:ENVX - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.01. The company had revenue of $9.72 million during the quarter, compared to the consensus estimate of $8.77 million. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. On average, equities analysts predict that Enovix Co. will post -1.01 EPS for the current fiscal year.
Insider Transactions at Enovix
In other news, CEO Rajendra K. Talluri sold 300,000 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the transaction, the chief executive officer now directly owns 2,045,301 shares of the company's stock, valued at approximately $19,123,564.35. The trade was a 12.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 15.70% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the business. Lpwm LLC bought a new position in shares of Enovix in the fourth quarter worth approximately $549,000. Vanguard Group Inc. raised its holdings in Enovix by 15.1% in the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock worth $171,458,000 after purchasing an additional 2,063,631 shares during the period. Haven Private LLC bought a new position in shares of Enovix during the 4th quarter valued at approximately $454,000. Register Financial Advisors LLC increased its stake in shares of Enovix by 172.8% in the fourth quarter. Register Financial Advisors LLC now owns 174,850 shares of the company's stock worth $1,901,000 after purchasing an additional 110,750 shares in the last quarter. Finally, Amundi increased its stake in Enovix by 360.8% in the 4th quarter. Amundi now owns 235,369 shares of the company's stock worth $2,558,000 after buying an additional 184,294 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors.
About Enovix
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.